BRICANYL TURBUHALER 0.5mg/actuation insufflation

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

terbutaline sulfate, Quantity: 0.5 mg/actuation

Available from:

AstraZeneca Pty Ltd

Pharmaceutical form:

Inhalation, powder for

Composition:

Excipient Ingredients:

Administration route:

Inhalation

Units in package:

100 Doses, 200 Doses

Prescription type:

(S3) Pharmacist Only Medicine

Therapeutic indications:

Relief of bronchospasm occurring in bronchial asthma, bronchitis and other bronchopulmonary conditions where bronchospasm is a complicating factor. Acute prophylaxis in conditions known to induce bronchospasm eg exercise induced asthma

Product summary:

Visual Identification: White to off-white rounded granules, which disintegrate to a fine powder upon slight pressure filled into a plastic inhaler.; Container Type: Inhaler - dry powder; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

1991-07-11